NDC 43742-1527

Virus Combination

Influenzinum (2018-2019), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6a, Human Herpesvirus 6b, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-barr Virus Nosode

Virus Combination is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Deseret Biologicals, Inc.. The primary component is Influenza A Virus A/singapore/gp1908/2015 Ivr-180 (h1n1) Antigen (formaldehyde Inactivated); Influenza A Virus A/singapore/infimh-16-0019/2016 Nib-104 (h3n2) Antigen (formaldehyde Inactivated); Influenza B Virus B/maryland/15/2016 Antigen (formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated); Human Herpesvirus 1; Human Herpesvirus 2; Human Herpesvirus 6; Human Herpesvirus 5; Hepatitis B Virus; Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen; Human Adenovirus B Serotype 7 Strain 55142 Antigen; Human Herpesvirus 4.

Product ID43742-1527_3d8a275b-5647-4841-b621-caaf1e0c4913
NDC43742-1527
Product TypeHuman Otc Drug
Proprietary NameVirus Combination
Generic NameInfluenzinum (2018-2019), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6a, Human Herpesvirus 6b, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-barr Virus Nosode
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2019-08-21
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameDeseret Biologicals, Inc.
Substance NameINFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 5; HEPATITIS B VIRUS; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN HERPESVIRUS 4
Active Ingredient Strength12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 43742-1527-1

30 mL in 1 BOTTLE, DROPPER (43742-1527-1)
Marketing Start Date2019-08-21
Marketing End Date2025-07-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43742-1527-1 [43742152701]

Virus Combination LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-08-21

Drug Details

Active Ingredients

IngredientStrength
INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_X]/mL

OpenFDA Data

SPL SET ID:02cb2384-0315-466c-9769-1956bfc63ecd
Manufacturer
UNII

NDC Crossover Matching brand name "Virus Combination" or generic name "Influenzinum (2018-2019), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6a, Human Herpesvirus 6b, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-barr Virus Nosode"

NDCBrand NameGeneric Name
43742-1415Virus CombinationInfluenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode
43742-1483Virus CombinationInfluenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode
43742-1527Virus CombinationInfluenzinum (2018-2019), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode
43742-1586Virus CombinationInfluenzinum (2019-2020), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.